Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-07

FDA Approved: NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Maxitrol (neomycin sulfate, polymyxin B sulfate, and dexamethasone) by Bausch & Lomb Incorporated, indicating labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAXITROL (Neomycin sulfate, polymyxin B sulfate and dexamethasone; neomycin and polymyxin B sulfates and dexamethasone)

Snippet

SUPPL AP for NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)